FibroGen to Present Interim Phase 2 Data on Pamrevlumab in Subjects with Duchenne Muscular Dystrophy at the Parent Project Muscular Dystrophy 2019 Annual Conference June 28, 2019 - NASDAQ Companies 0 » View More News for June 28, 2019
